Atlas Trials

Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy

Clinical trial NCT00554918 · COMPLETED

Trial details

NCT number
NCT00554918
Sponsor
University Hospital Birmingham
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic CancerProstate Cancer
Start date
2005-02-01
Primary completion
2008-12-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.